I. Théodorou

发表

CCR5Δ32 Protein Expression and Stability Are Critical for Resistance to Human Immunodeficiency Virus Type 1 In Vivo

R. Tubiana, L. Meyer, L. Agrawal, 2007, Journal of Virology.

MICA haplotypic diversity

L. Laloux, S. Bahram, N. Fodil, 1999, Immunogenetics.

A human TCR-Ig chimeric protein used to generate a TCR α chain variable region-specific mAb☆

P. Debré, R. Mariuzza, G. Bismuth, 1990 .

Clustering of End Stage Renal Disease Patients by Dimensionality Reduction Algorithms According to Lymphocyte Senescence Markers

A. Papagianni, I. Tsouchnikas, A. Xochelli, 2022, Frontiers in Immunology.

Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients

F. Raffi, C. Leport, N. Duchange, 2005, European Journal of Human Genetics.

Wild type and H43Y variant of human TRIM5α show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro

S. Matsushita, B. Autran, P. Debré, 2007, Immunogenetics.

CLINICAL AND BIOLOGICAL CHARACTERISTICS OF HUMAN IMMUNODEFICIENCY VIRUS – INFECTED AND UNINFECTED INTRAVASCULAR DRUG USERS

P. Debré, H. Fleury, W. Lowenstein, 1999 .

Influence of the R22H variant of macrophage inflammatory protein 1β/Lag-1 in HIV-1 survival

P. Debré, L. Meyer, J. Delfraissy, 2005, AIDS.

CCR5 D32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1

P. Debré, C. Rouzioux, L. Meyer, 1999 .

CCR5 Δ32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1

P. Debré, C. Rouzioux, L. Meyer, 1999 .

CONCISE COMMUNICATIONS CCR5 D32 Deletion and Reduced Risk of Toxoplasmosis in Persons Infected with Human Immunodeficiency Virus Type 1

P. Debré, C. Rouzioux, L. Meyer, 1999 .

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non‐1 HCV genotypes

Z. Kutalik, F. Negro, J. Dufour, 2012, Hepatology.

FAS promoter polymorphisms correlate with activity grade in hepatitis C patients

P. Debré, D. Vidaud, T. Poynard, 2005, European journal of gastroenterology & hepatology.

Genome-Wide Association Study of HIV-Related Lipoatrophy in Thai Patients: Association of a DLGAP1 Polymorphism with Fat Loss

T. Shioda, S. Khusmith, J. Delfraissy, 2015, AIDS research and human retroviruses.

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

P. Marcellin, F. Carrat, F. Zoulim, 2015, PloS one.

Distribution of the CCR5 gene 32 base pair deletion and SDF1–3'A variant in healthy individuals from different populations

C. Carcassi, P. Debré, D. Charron, 1998, Immunogenetics.

CCR5Δ32 59537-G/A Promoter Polymorphism Is Associated with Low Translational Efficiency and the Loss of CCR5Δ32 Protective Effects

R. Tubiana, L. Agrawal, Qingwen Jin, 2007, Journal of Virology.

Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.

P. Debré, K. Fadhlaoui-Zid, A. Slim, 2007, Human immunology.

Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression.

E. Génin, P. Debré, L. Meyer, 2003, Journal of acquired immune deficiency syndromes.

Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.

C. Leport, N. Duchange, C. Hervé, 2002, Pharmacogenetics.

TRAF1/C5 rs3761847 SNP Is Associated with Severe Pattern of Rheumatoid Arthritis in Greek Patients

P. Boura, A. Sarantopoulos, I. Théodorou, 2016 .

AB0001 First description and functional proteomic analysis of a protective for rheumatoid arthritis gene polymorphism

A. Notopoulos, P. Boura, A. Sarantopoulos, 2017 .

Genomics , genetic basis of disease and HLA / T cell recognition

Jane Worthington, T. Radstake, A. Herrick, 2022 .

Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users 1

D. Scott‐Algara, L. X. Truong, F. Barré-Sinoussi, 2003, The Journal of Immunology.

Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease

B. Arnulf, I. Théodorou, D. Bengoufa, 2022, British journal of haematology.

Association of HLA Class-I and Inhibitory KIR Genotypes in Gabonese Patients Infected by Chikungunya or Dengue Type-2 Viruses

N. Wauquier, E. Leroy, V. Vieillard, 2014, PloS one.

Patterns of 1,748 Unique Human Alloimmune Responses Seen by Simple Machine Learning Algorithms

I. Doxiadis, George Petasis, M. Carmagnat, 2020, Frontiers in Immunology.

A natural CCL5/RANTES variant antagonist for CCR1 and CCR3

P. Debré, K. Lole, F. Barré-Sinoussi, 2006, Immunogenetics.

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy

Sebastiaan Overeem, Poul Jennum, Johannes Mathis, 2010, Nature Genetics.

Corrigendum: Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy

A. Valsesia, J. Beckmann, Z. Kutalik, 2011, Nature Genetics.

Successful response in a case of severe pustular psoriasis after interleukin‐1β inhibition

A. Giatromanolaki, I. Kotsianidis, P. Skendros, 2017, The British journal of dermatology.

Biochemical and HIV-1 Coreceptor Properties of K26R, a New CCR5 Variant in China's Sichuan Population

P. Debré, H. Xing, Y. Shao, 2005, Journal of acquired immune deficiency syndromes.

New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia

P. Debré, D. Scott‐Algara, G. Bismuth, 2004, AIDS.

Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals.

D. Scott‐Algara, L. X. Truong, F. Barré-Sinoussi, 2007, Blood.

MIC genes in non-human primates.

P. Debré, I. Théodorou, P. Pellet, 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.